Influenza A Reduction

Vivienne Mahon, Science & Quality Manager
Airmid Health Group Ltd., Ireland
Full Report


To evaluate the efficacy of the Defend 1050 on removing Influenza A.


Testing of the Defend 1050 was conducted in a 28.5 m3 environmental test chamber. The chamber was preconditioned to 68±5ºF and 50±10% relative humidity prior to commencement of the tests. For the test runs, the Defend 1050 was placed on the floor in the center of the chamber.

Summary of Results

The Defend 1050 was effective in reducing airborne Influenza A aerosols in the test chamber, reaching 99.9% airborne virus reduction within the first 10 – 20 minutes of operation at max speed.

Defend 1050 achieved 99.9% reduction of Influenza A

Contact Us

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750